How one company found itself in the right place at the right time to help the pharma industry operate throughout Covid-19.
In March of 2020, businesses all over the world panicked as countries went into lockdown due to the spread of coronavirus. For the life sciences industry, the pressure would have been immense. The global necessity not just for coronavirus test kits and diagnostics, but for the thousands upon thousands of healthcare products that are essential to the wellbeing of patients all across the globe, means that the life sciences industry is not one that can simply stop operating without consequence.
“Every company had to respond quickly when the pandemic originally happened but none more so than the pharmaceutical industry. There was a very sudden increase in demand for services and at the same time – as with everyone else – a decrease in the ability to provide them,” said Devon Copley, CEO of remote communications company Avatour.